Cutler Group LLC / CA - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 52 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$1
-50.0%
2,0000.0%0.00%
Q2 2023$20.0%2,0000.0%0.00%
Q1 2023$20.0%2,0000.0%0.00%
Q4 2022$2
-99.9%
2,0000.0%0.00%
Q3 2022$2,0000.0%2,0000.0%0.00%
Q2 2022$2,000
-50.0%
2,0000.0%0.00%
Q1 2022$4,000
-20.0%
2,000
-4.8%
0.00%
Q4 2021$5,000
-58.3%
2,100
-32.3%
0.00%
-100.0%
Q3 2021$12,000
-47.8%
3,100
-80.7%
0.00%0.0%
Q2 2021$23,000
+1050.0%
16,100
+1138.5%
0.00%
Q2 2020$2,0000.0%1,3000.0%0.00%
Q1 2020$2,000
-33.3%
1,3000.0%0.00%
Q4 2019$3,0001,3000.0%0.00%
Q3 2019$0
-100.0%
1,3000.0%0.00%
Q2 2019$1,0000.0%1,3000.0%0.00%
Q1 2019$1,0000.0%1,3000.0%0.00%
Q4 2018$1,000
-98.8%
1,300
-91.6%
0.00%
-100.0%
Q2 2018$84,000
+833.3%
15,400
+1611.1%
0.01%
+600.0%
Q1 2018$9,0009000.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q1 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,462,500$11,993,0006.16%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$6,410,0002.56%
AJU IB Investment Co., Ltd. 293,555$1,430,0000.82%
RTW INVESTMENTS, LP 4,206,765$20,487,0000.31%
Carmignac Gestion 3,419,877$16,655,0000.19%
EAM Investors, LLC 247,561$1,206,0000.19%
Curi Wealth Management, LLC 25,000$121,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,542,0000.03%
TWO SIGMA ADVISERS, LP 990,000$4,821,0000.01%
CAXTON ASSOCIATES LP 24,677$120,0000.01%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders